Cargando…
Efficacy of the multidisciplinary tumor board conference in gynecologic oncology: A prospective study
Evidence has shown that multidisciplinary tumor board conferences (MTBCs) improve patient management for various cancer types. However, few retrospective studies have investigated MTBC efficacy for patients with gynecologic cancers. Here, we prospectively aimed to evaluate how MTBCs influence patien...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728725/ https://www.ncbi.nlm.nih.gov/pubmed/29310324 http://dx.doi.org/10.1097/MD.0000000000008089 |
_version_ | 1783286059630592000 |
---|---|
author | Lee, Banghyun Kim, Kidong Choi, Jin Young Suh, Dong Hoon No, Jae Hong Lee, Ho-Young Eom, Keun-Yong Kim, Haeryoung Hwang, Sung Il Lee, Hak Jong Kim, Yong Beom |
author_facet | Lee, Banghyun Kim, Kidong Choi, Jin Young Suh, Dong Hoon No, Jae Hong Lee, Ho-Young Eom, Keun-Yong Kim, Haeryoung Hwang, Sung Il Lee, Hak Jong Kim, Yong Beom |
author_sort | Lee, Banghyun |
collection | PubMed |
description | Evidence has shown that multidisciplinary tumor board conferences (MTBCs) improve patient management for various cancer types. However, few retrospective studies have investigated MTBC efficacy for patients with gynecologic cancers. Here, we prospectively aimed to evaluate how MTBCs influence patient management in gynecologic oncology. This prospective study included 85 consecutive cases that were presented at gynecologic oncology MTBCs in our tertiary university hospital between January 2015 and April 2016. The primary endpoint was treatment plan change rate, which included both major and minor changes. Major changes were defined as exchange, addition, or subtraction of treatment modality. Minor changes included all other, such as intramodality changes or treatment time changes. The secondary endpoints were the change rates of diagnosis, diagnostic work-up, and radiological and pathological findings. The treatment plan change rate, irrespective of changes in diagnostic work-up, was 27.1%, which included 10.6% major and 16.5% minor changes. Among the treatment plan changes, changes in the treatment plan change rate alone were noted in 16.5% of cases, and changes in diagnosis and radiological findings occurred in 7.1% and 3.5% of cases, respectively. Diagnosis and radiological findings, irrespective of changes in diagnostic work-up, were also changed in 9.4% and 10.6% of cases, respectively. However, there were no changes in pathological findings. Moreover, there was a change of diagnostic method for further work-up in 23.5% of cases. The implementation rate of MTBC-determined treatment changes was 91.8%. Gynecologic oncology MTBCs resulted in considerable changes in treatment plans. Diagnosis, diagnostic work-up, and radiological findings were influenced by MTBCs. The data emphasize the importance of adopting a multidisciplinary team approach for gynecologic cancer management. |
format | Online Article Text |
id | pubmed-5728725 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-57287252017-12-20 Efficacy of the multidisciplinary tumor board conference in gynecologic oncology: A prospective study Lee, Banghyun Kim, Kidong Choi, Jin Young Suh, Dong Hoon No, Jae Hong Lee, Ho-Young Eom, Keun-Yong Kim, Haeryoung Hwang, Sung Il Lee, Hak Jong Kim, Yong Beom Medicine (Baltimore) 5600 Evidence has shown that multidisciplinary tumor board conferences (MTBCs) improve patient management for various cancer types. However, few retrospective studies have investigated MTBC efficacy for patients with gynecologic cancers. Here, we prospectively aimed to evaluate how MTBCs influence patient management in gynecologic oncology. This prospective study included 85 consecutive cases that were presented at gynecologic oncology MTBCs in our tertiary university hospital between January 2015 and April 2016. The primary endpoint was treatment plan change rate, which included both major and minor changes. Major changes were defined as exchange, addition, or subtraction of treatment modality. Minor changes included all other, such as intramodality changes or treatment time changes. The secondary endpoints were the change rates of diagnosis, diagnostic work-up, and radiological and pathological findings. The treatment plan change rate, irrespective of changes in diagnostic work-up, was 27.1%, which included 10.6% major and 16.5% minor changes. Among the treatment plan changes, changes in the treatment plan change rate alone were noted in 16.5% of cases, and changes in diagnosis and radiological findings occurred in 7.1% and 3.5% of cases, respectively. Diagnosis and radiological findings, irrespective of changes in diagnostic work-up, were also changed in 9.4% and 10.6% of cases, respectively. However, there were no changes in pathological findings. Moreover, there was a change of diagnostic method for further work-up in 23.5% of cases. The implementation rate of MTBC-determined treatment changes was 91.8%. Gynecologic oncology MTBCs resulted in considerable changes in treatment plans. Diagnosis, diagnostic work-up, and radiological findings were influenced by MTBCs. The data emphasize the importance of adopting a multidisciplinary team approach for gynecologic cancer management. Wolters Kluwer Health 2017-12-01 /pmc/articles/PMC5728725/ /pubmed/29310324 http://dx.doi.org/10.1097/MD.0000000000008089 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-NoDerivatives License 4.0, which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. http://creativecommons.org/licenses/by-nd/4.0 |
spellingShingle | 5600 Lee, Banghyun Kim, Kidong Choi, Jin Young Suh, Dong Hoon No, Jae Hong Lee, Ho-Young Eom, Keun-Yong Kim, Haeryoung Hwang, Sung Il Lee, Hak Jong Kim, Yong Beom Efficacy of the multidisciplinary tumor board conference in gynecologic oncology: A prospective study |
title | Efficacy of the multidisciplinary tumor board conference in gynecologic oncology: A prospective study |
title_full | Efficacy of the multidisciplinary tumor board conference in gynecologic oncology: A prospective study |
title_fullStr | Efficacy of the multidisciplinary tumor board conference in gynecologic oncology: A prospective study |
title_full_unstemmed | Efficacy of the multidisciplinary tumor board conference in gynecologic oncology: A prospective study |
title_short | Efficacy of the multidisciplinary tumor board conference in gynecologic oncology: A prospective study |
title_sort | efficacy of the multidisciplinary tumor board conference in gynecologic oncology: a prospective study |
topic | 5600 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728725/ https://www.ncbi.nlm.nih.gov/pubmed/29310324 http://dx.doi.org/10.1097/MD.0000000000008089 |
work_keys_str_mv | AT leebanghyun efficacyofthemultidisciplinarytumorboardconferenceingynecologiconcologyaprospectivestudy AT kimkidong efficacyofthemultidisciplinarytumorboardconferenceingynecologiconcologyaprospectivestudy AT choijinyoung efficacyofthemultidisciplinarytumorboardconferenceingynecologiconcologyaprospectivestudy AT suhdonghoon efficacyofthemultidisciplinarytumorboardconferenceingynecologiconcologyaprospectivestudy AT nojaehong efficacyofthemultidisciplinarytumorboardconferenceingynecologiconcologyaprospectivestudy AT leehoyoung efficacyofthemultidisciplinarytumorboardconferenceingynecologiconcologyaprospectivestudy AT eomkeunyong efficacyofthemultidisciplinarytumorboardconferenceingynecologiconcologyaprospectivestudy AT kimhaeryoung efficacyofthemultidisciplinarytumorboardconferenceingynecologiconcologyaprospectivestudy AT hwangsungil efficacyofthemultidisciplinarytumorboardconferenceingynecologiconcologyaprospectivestudy AT leehakjong efficacyofthemultidisciplinarytumorboardconferenceingynecologiconcologyaprospectivestudy AT kimyongbeom efficacyofthemultidisciplinarytumorboardconferenceingynecologiconcologyaprospectivestudy |